JF
LENZ

Jump Financial’s LENZ Therapeutics LENZ Stock Holding History

Jump Financial’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$637K Buy
112,182
+11,982
+12% +$96.6K 0.01% 1378
2026
Q1 		$917K Buy
100,200
+59,349
+145% +$834K 0.01% 966
2025
Q4 		$654K Buy
+40,851
New +$1.19M 0.01% 1171
2024
Q3 		– Sell
-22,611
Closed -$391K – 2196
2024
Q2 		$391K Buy
+22,611
New +$395K 0.01% 1241
2022
Q4 		– Sell
-1,543
Closed -$34K – 2093
2022
Q3 		$34K Sell
1,543
-6,445
-81% -$154K ﹤0.01% 1508
2022
Q2 		$154K Buy
+7,988
New +$178K 0.01% 1362

Other funds holding LENZ

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
AWG
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
7IH
72 Investment Holdings Stamford, Connecticut $50M AUM 647.58% 1-Year Est. Return

Jump Financial's LENZ Position: Q2 2026 in Review

Jump Financial increased its LENZ Therapeutics (LENZ) stake by 12% in Q2 2026, buying an estimated $96.6K and bringing the position to 112,182 shares worth $637K. The position accounts for 0.01% of the portfolio, ranked #1378.

Jump Financial first reported a position in LENZ in Q2 2022 and has held it in 6 quarters since. The position peaked at $917K in Q1 2026. 145 funds tracked by Wall St. Rank hold LENZ as of Q2 2026.

  • Jump Financial held 112,182 shares of LENZ Therapeutics worth $637K as of Q2 2026.
  • Jump Financial bought 11,982 LENZ Therapeutics shares in Q2 2026, an estimated $96.6K.
  • LENZ Therapeutics made up 0.01% of Jump Financial's portfolio in Q2 2026, its #1378 holding.
  • Jump Financial first reported a position in LENZ Therapeutics in Q2 2022 and has held it in 6 quarters since.
  • Jump Financial's LENZ Therapeutics position peaked at $917K in Q1 2026.
  • 145 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.